Literature DB >> 2013838

The pharmacokinetics of aspirin in rats and the effect of buffer.

C J Fu1, S Melethil, W D Mason.   

Abstract

Aspirin (acetylsalicyclic acid) was administered to rats intravenously, orally, and intraintestinally at different doses or in different dosage forms. The distribution and elimination kinetics of aspirin in rats following intravenous administration were best described by a two-compartmental open system and were dose independent up to 15 mg/kg. The terminal elimination half-life following intravenous dosing (10 mg/kg) was 3.36 +/- 0.85 min (n = 15) with the clearance being 8.40 +/- 1.24 L/(kg.hr). Intravenous distribution and elimination kinetics of aspirin in rats were not influenced by an orally administered buffered solution with a buffer capacity of 0.933 mEq ANC (acid neutralizing capacity) per kg of body weight. However, this orally buffered solution did change the gastrointestinal absorption kinetics of aspirin in rats. The absolute bioavailable dose of aspirin was 56.6 +/- 10.4% (n = 6) following its administration in an unbuffered solution while it was only 31.8 +/- 8.0% (n = 6) following administration in the buffered solution. The corresponding values of the absolute bioavailable doses were 43.4 +/- 3.7% and 25.5 +/- 1.8% following intraintestinal administration. The lower systemic availability of aspirin in the presence of buffer is attributed to a greater fraction of the administered dose becoming available for absorption from the intestine where the extraction efficiency is higher than that in the stomach.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2013838     DOI: 10.1007/bf01073867

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  31 in total

1.  Absorption of drugs from the rat small intestine.

Authors:  L S SCHANKER; D J TOCCO; B B BRODIE; C A HOGBEN
Journal:  J Pharmacol Exp Ther       Date:  1958-05       Impact factor: 4.030

2.  Absorption kinetics of aspirin in man following oral administration of an aqueous solution.

Authors:  M Rowland; S Riegelman; P A Harris; S D Sholkoff
Journal:  J Pharm Sci       Date:  1972-03       Impact factor: 3.534

3.  Reduction or prevention of aspirin-induced occult gastrointestinal blood loss in man.

Authors:  J R Leonards; G Levy
Journal:  Clin Pharmacol Ther       Date:  1969 Jul-Aug       Impact factor: 6.875

4.  Influence of the route of administration on the area under the plasma concentration-time curve.

Authors:  P A Harris; S Riegelman
Journal:  J Pharm Sci       Date:  1969-01       Impact factor: 3.534

5.  Kinetics of aspirin absorption following oral administration of six aqueous solutions with different buffer capacities.

Authors:  W D Mason
Journal:  J Pharm Sci       Date:  1984-09       Impact factor: 3.534

6.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

7.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

8.  The absorption of acetylsalicylic acid from the stomach in relation to intragastric pH.

Authors:  G Dotevall; G Ekenved
Journal:  Scand J Gastroenterol       Date:  1976       Impact factor: 2.423

Review 9.  Hematologic perturbations associated with salicylate.

Authors:  B M Rothschild
Journal:  Clin Pharmacol Ther       Date:  1979-08       Impact factor: 6.875

10.  Nonlinear pharmacokinetics of aspirin in rats.

Authors:  M G Wientjes; G Levy
Journal:  J Pharmacol Exp Ther       Date:  1988-06       Impact factor: 4.030

View more
  5 in total

1.  Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin.

Authors:  Priscilla Jaichander; Krithika Selvarajan; Mahdi Garelnabi; Sampath Parthasarathy
Journal:  J Lipid Res       Date:  2008-06-02       Impact factor: 5.922

2.  New approaches for the assessment of platelet activation status in thrombus under flow condition using confocal microscopy.

Authors:  Natalia Marcinczyk; Agata Golaszewska; Tomasz Misztal; Anna Gromotowicz-Poplawska; Tomasz Rusak; Ewa Chabielska
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-12-13       Impact factor: 3.000

3.  Nonsteroidal anti-inflammatory drugs and acetaminophen ameliorate muscular mechanical hyperalgesia developed after lengthening contractions via cyclooxygenase-2 independent mechanisms in rats.

Authors:  Tetsuhiro Shimodaira; Shigeo Mikoshiba; Toru Taguchi
Journal:  PLoS One       Date:  2019-11-06       Impact factor: 3.240

4.  Effects of dexamethasone and acetylsalicylic acid on inflammation caused by Complete Freund's adjuvant in the naked mole rat (Heterocephalus glaber).

Authors:  J K N Thuo; P K Towett; T I Kanui; K S P Abelson
Journal:  Heliyon       Date:  2022-02-08

5.  Acetylsalicylic Acid Suppresses Alcoholism-Induced Cognitive Impairment Associated with Atorvastatin Intake by Targeting Cerebral miRNA155 and NLRP3: In Vivo, and In Silico Study.

Authors:  Doaa I Mohamed; Dalia Alaa El-Din Aly El-Waseef; Enas S Nabih; Omnyah A El-Kharashi; Hanaa F Abd El-Kareem; Hebatallah H Abo Nahas; Basel A Abdel-Wahab; Yosra A Helmy; Samar Zuhair Alshawwa; Essa M Saied
Journal:  Pharmaceutics       Date:  2022-02-27       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.